Alterity Therapeutics (ATHE) Other Non Operating Income (2015 - 2025)

Alterity Therapeutics' Other Non Operating Income history runs 10 years deep, the most recent figure standing at $12282.6 for Q4 2025.

• In Q4 2025, Other Non Operating Income rose 107.28% year-over-year to $12282.6; the TTM figure through Dec 2025 stood at -$449955.0 (up 66.67% YoY), while the FY2025 annual figure was -$42980.1, down 124.97% from the prior year.
• Other Non Operating Income was $12282.6 for Q4 2025 at Alterity Therapeutics, up from -$168754.2 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $12282.6 in Q4 2025 to a low of -$887856.6 in Q4 2021.
• Historically, Other Non Operating Income has averaged -$267562.3 across 5 years, with a median of -$168754.2 in 2024.
• The sharpest annual moves came in 2024 and 2025: Other Non Operating Income tumbled 7673.09% in 2024, then surged 107.28% in 2025.
• A 5-year view of Other Non Operating Income shows it stood at -$887856.6 in 2021, then jumped by 66.69% to -$295711.7 in 2022, then surged by 100.75% to $2228.3 in 2023, then sank by 7673.09% to -$168754.2 in 2024, then jumped by 107.28% to $12282.6 in 2025.
• The last three Other Non Operating Income figures came in at $12282.6 (Q4 2025), -$168754.2 (Q4 2024), and $2228.3 (Q4 2023), per Business Quant data.